Bullous Pemphigoid Clinical Trials

Currently Enrolling

  • Regeneron Protocol R668-BP-1902: A multi-center, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of dupilumab in adult patients with bullous pemphigoid.  |  Learn More »  |  Request to Join This Study »

 

View Other Clinical Trials